Myomar Launches Product
Three months after it won Health Canada approval for its urine test to monitor muscle health, Halifax-based Myomar Molecular is going to market in Nova Scotia, with a national launch and capital raise to follow.
In an interview Thursday, CEO Rafaela Andrade said the company has so far signed on with 20 distribution partners in Nova Scotia. The raise will go towards funding the national expansion